Lixte Biotechnology (LIXT) Institutional Ownership $2.45 +0.04 (+1.66%) As of 09:37 AM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lixte Biotechnology (NASDAQ:LIXT)CurrentInstitutional OwnershipPercentage5.10%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$65.81K Get LIXT Insider Trade Alerts Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LIXT Institutional Buying and Selling by Quarter Lixte Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/13/2025FNY Investment Advisers LLC39,219$82K0.0%-45.3%1.744% 6/5/2023EP Wealth Advisors LLC2,211$786K0.0%N/A0.013% 2/9/2023Ethos Financial Group LLC248,084$126K0.0%N/A1.490% 8/12/2022Almanack Investment Partners LLC.248,084$185K0.0%-66.7%1.490% 11/9/2021BlackRock Inc.13,425$28K0.0%+191.9%0.098% 11/4/2021Almanack Investment Partners LLC.806,050$1.68M0.1%-17.9%5.863% 8/16/2021State Street Corp33,600$102K0.0%N/A0.244% 8/16/2021Sabby Management LLC65,511$199K0.0%-17.8%0.477% 8/13/2021Renaissance Technologies LLC50,900$154K0.0%N/A0.370% 8/13/2021Vanguard Group Inc.74,383$225K0.0%N/A0.544% 8/4/2021Almanack Investment Partners LLC.982,046$2.98M0.3%-5.8%7.189% 5/21/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/18/2021Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/11/2021Almanack Investment Partners LLC.1,042,105$3.43M0.3%N/A7.698% 2/16/2021Santa Monica Partners LP166,667$528K0.4%N/A1.347% (Data available from 1/1/2016 forward) LIXT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LIXT shares? During the previous two years, the following institutional investors and hedge funds held shares of Lixte Biotechnology shares: EP Wealth Advisors LLC ($786K), and Ethos Financial Group LLC ($126K), FNY Investment Advisers LLC ($82K).Learn more on LIXT's institutional investors. What percentage of Lixte Biotechnology stock is owned by institutional investors? 5.10% of Lixte Biotechnology stock is owned by institutional investors. Learn more on LIXT's institutional investor holdings. Which institutional investors have been buying Lixte Biotechnology stock? The following institutional investors have purchased Lixte Biotechnology stock in the last 24 months: Ethos Financial Group LLC ($248.08K), and EP Wealth Advisors LLC ($2.21K). How much institutional buying is happening at Lixte Biotechnology? Institutional investors have bought a total of 250,295 shares in the last 24 months. This purchase volume represents approximately $1.28M in transactions. Which Lixte Biotechnology major shareholders have been selling company stock? The following institutional investors have sold Lixte Biotechnology stock in the last 24 months: FNY Investment Advisers LLC ($32.42K). How much institutional selling is happening at Lixte Biotechnology? Institutional investors have sold a total of 32,419 shares in the last 24 months. This volume of shares sold represents approximately $65.81K in transactions. Related Companies CARA Major Shareholders TENX Major Shareholders XCUR Major Shareholders ATHA Major Shareholders GOVX Major Shareholders MIRA Major Shareholders BTAI Major Shareholders CYTH Major Shareholders APRE Major Shareholders BFRG Major Shareholders This page (NASDAQ:LIXT) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersCharles Payne Wants You Prepared for 2025Charles Payne Wants You Prepared for 2025 There's no denying that market volatility, inflation, and recessi...Unstoppable Prosperity | SponsoredGreatest crypto bull market in history?A crypto storm is coming Right now, conditions are in place for a historic move we expect will be the great...Stansberry Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in JanuaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIXT Stock Alerts